Assentia Unveils New SaaS-Based Applications


Assentia has unveiled two new proprietary, SaaS-based applications, GrantPay™ and GrantPact™, designed to aid Assentia in merging its global knowledge in clinical trial contract negotiations and investigative site payments with functional technology platforms.

Assentia utilizes GrantPay™ to provide investigator site payments on a multi-currency, global scale in addition to granular forecasting and customizable reporting to assist its clients' needs and obligations.

GrantPact™ is Assentia's proprietary platform supporting its international team in negotiating and tracking global clinical trial agreements, including housing previously negotiated legal clauses with study sites worldwide.


Assentia Unveils Proprietary Software, GrantPay™ and GrantPact™, to Aid in Accelerating Clinical Trial Study-Startup and Investigator Payments. (2023, March 9). Cision PR Newswire.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.